Regions :: North America :: U.S.
Merck & Co. Sells U.S. Pharma Plant to Market Entrant
10:33 AM MST | January 14, 2008 | Alex Scott
Merck & Co. says it has sold a pharmaceuticals manufacturing facility at Riverside, PA to manufacturing services firm PRWT Services (Philadelphia). The Riverside plant manufactures antibiotics for humans and animals. PRWT will supply product from the facility at Riverside to Merck & Co. for the next five years under terms of the agreement. PRWT estimates the supply deal to be worth $100 million-$200 million in total. Acquiring the Riverside plant marks PRWT’s entry into the pharma manufacturing sector. PRWT has established a subsidiary...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee